Phathom Pharmaceuticals (PHAT) Inventory Average (2023 - 2026)

Phathom Pharmaceuticals (PHAT) has 4 years of Inventory Average data on file, last reported at $6.0 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 88.67% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 88.67% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, up 97.6% from the prior year.
• Inventory Average for Q1 2026 stood at $6.0 million, up from $4.6 million in the prior quarter.
• Over the last five years, Inventory Average for PHAT reached as high as $6.0 million in Q1 2026 and fell as low as $111000.0 in Q3 2023.
• Historically, Inventory Average has averaged $2.8 million across 4 years, with a median of $3.2 million in 2024.
• Across the five-year window, Inventory Average soared 2281.98% in 2024 and jumped 33.17% in 2025, its largest moves.
• Year by year, Inventory Average stood at $659500.0 in 2023, then jumped by 379.08% to $3.2 million in 2024, then surged by 44.47% to $4.6 million in 2025, then surged by 31.73% to $6.0 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $6.0 million in Q1 2026, $4.6 million in Q4 2025, and $3.5 million in Q3 2025.